Revisiting the epidemiological standard of preeclampsia: Primigravidity or primipaternity?

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 84, Issue 1, 1999, Pages 37-41

  Robillard, Pierre Yves ^a   Dekker, Gustaaf A ^b   Hulsey, Thomas C ^c  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Epidemiology; Preeclampsia; Primipaternity

Indexed keywords

ARTICLE; CULTURAL ANTHROPOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; MATERNAL HYPERTENSION; MATHEMATICAL MODEL; PARENT; PREECLAMPSIA; PREVALENCE; PRIMIGRAVIDA; PRIORITY JOURNAL; THEORY;

EID: 0032944311     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(98)00250-4     Document Type: Article

References (33)

1. MacGillivray I. Epidemiology of pre-eclampsia and eclampsia. In: MacGillivray I, editor. Preeclampsia. London: WB Saunders, 1983:8-22.
2. MacGillivray I. Factors predisposing to the development of preeclampsia. In: MacGillivray I, editor. Preeclampsia. London: WB Saunders, 1983:23-55.
3. Saftlas A.F., Olson D.R., Franks A.L., Atrash H.K., Pokras R. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 163:1990;460-465.
4. Baird D. Epidemiological aspects of hypertensive pregnancy. Clin Obstet Gynecol. 4:1977;531-548.
5. Davies A.M., Czaczkes J.W., Sadovsky E., Prywes R., Weiskopf P., Sterk V.V. Toxemia of pregnancy in Jerusalem. I Epidemiological studies of a total community. Israel J Med Sci. 6:1970;253-266.
6. Dieckmann WJ. Incidence of eclampsia and other toxemias of pregnancy. In: Dieckmann WJ, editor. The toxemias of pregnancy. St. Louis: CV Mosby, 1952:33-57.
7. Högstedt S.E., Lindberg B.S., Lindmark G. An epidemiological study of hypertension during pregnancy in a Swedish population. Clin Exp Hyper Preg. B7:1988;317-329.
8. Vara P., Timonen S., Lokki O. Toxemia of late pregnancy, a statistical study. Acta Obstet Gynecol Scand. 44:1965;3-45.
9. World Health Organization. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988;158:80-83.
10. Eskenazi B., Fenster L., Sidney S. A multivariate analysis of risk factors for preeclampsia. J Am Med Assoc. 266:1991;237-241.
11. Jeffcoate T.N.A. Pre-eclampsia and eclampsia: The disease of theories. Proc Royal Soc Med. 59:1966;397.
12. Robillard P.Y., Hulsey T.C., Perianin J., Janky E., Miri E.H., Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet. 344:1994;973-975.
13. Beer A.E., Need J.A. Immunological aspects of preeclampsia/eclampsia. Birth Defects. 21:1985;131-154.
14. Redman C.W.G. Immunology of preeclampsia. Semin Perinatol. 15:1991;257-262.
15. McLaren A. A history of contraception from antiquity to the present day. London: Blackwell, 1990.
16. Léridon H. Demographic and statistical aspects of human fertility. In: Thibault C, Levasseur MC, Hunter RHF editors. Reproduction in mammals and man. Paris: Ellipses, 1993:644-51.
17. Goody J. Preface. In: Burguière A, Klapisch-Zuber C, Segalen M, Zonabend F, editors. Histoire de la famille. 3. Le choc des modernités. Paris: Armand Colin, 1986:7-17.
18. Goode WJ. World revolution and family patterns. London: Collier Macmillan, 1970, 2nd ed.
19. Charbit Y. Caribbean family structure: past research and recent evidence from the WFS on matrifocality. Netherlands: International Statistical Institute, 1984.
20. Lardinois R. En Inde, la famille, l'Etat, la femme. In: Burguière A, Klapisch-Zuber C, Segalen M, Zonabend F, editors. Histoire de la famille. 3. Le choc des modernités. Paris: Armand Colin, 1986:351-91.
21. Davies AM. Epidemiology of pregnancy toxemias. In: Davies AM, editor. Geographical epidemiology of the toxemias of pregnancy. Springfield: Thomas CC, 1971:8-75.
22. Need J.A., Bell B., Meffin E., Jones W.R. Pre-eclampsia in pregnancies from donor inseminations. J Reprod Immunol. 5:1983;329-338.
23. Clark D.A. Does immunological intercourse prevent pre-eclampsia? Lancet. 344:1994;969-970.
24. Deneys V., Van Lierde M., De Bruyère M. Immunologic tolerance to the foetal allograft. Presse Med. 24:1995;1651-1657.
25. Chaouat G, Martal J. Cytokines et gestation. In: Cavaillon JM, editor. Les Cytokines. Paris: Masson, 1996:471-500.
26. Beer AE. Immunology of reproduction. In: Samter M, editor. Immunological diseases. Boston: Little, Brown, 1990:329-60.
27. Wegman T.G. Fetal protection against abortion: it is immunosuppression or immunostimulation? Ann Immunol Inst Pasteur. 135D:1984;309-311.
28. Wegmann T.G., Lin H., Guilbert L., Mossman T.H. Bi-directional cytokines interactions in the materno fetal relationship: successful allopregnancy is a Th2 phenomenon. Immunol Today. 14:1993;353-355.
29. Claman HM. Recurrent pregnancy loss, immunologic and nonimmunologic aspects. In: Claman HM, editor. The immunology of human pregnancy. Totowa, NJ: Humana Press, 1993:171-212.
30. Beer A.E. Immunology contraception and preeclampsia. J Am Med Assoc. 262:1989;3184.
31. Haig D. Genomic imprinting and the theory of parent-offspring conflict. Semin Devel Biol. 3:1992;153-160.
32. Haig D. Genetic conflicts in human pregnancy. Q Rev Biol. 68:1993;495-532.
33. James H.J. Coital rate and pregnancy-induced hypertension. Hum Reprod. 12(6):1997;1311-1312.